Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru

Streptococcus pneumoniae upper respiratory infections and pneumonia are often treated with macrolides, but recently macrolide resistance is becoming an increasingly important problem. The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the National Immunization Program of Peru in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzales, Brayan E., Mercado, Erik H., Pinedo-Bardales, Maria, Hinostroza, Noemi, Campos, Francisco, Chaparro, Eduardo, Del Águila, Olguita, Castillo, María E., Saenz, Andrés, Reyes, Isabel, Ochoa, Theresa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125093/
https://www.ncbi.nlm.nih.gov/pubmed/35615398
http://dx.doi.org/10.3389/fcimb.2022.866186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125093/
https://www.ncbi.nlm.nih.gov/pubmed/35615398
http://dx.doi.org/10.3389/fcimb.2022.866186

Ejemplares similares